HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

4th Edition of International Heart Congress

June 22-24,2026 | Hybrid Event

June 22 -24, 2026 | Barcelona, Spain

Cardiac Gene Therapy

Cardiac Gene Therapy

Cardiac gene therapy represents a cutting-edge approach in the realm of cardiovascular medicine, holding immense promise for the treatment of various heart-related conditions. This innovative therapeutic strategy involves the introduction of specific genes into the heart with the aim of correcting or modulating genetic defects, enhancing myocardial function, and mitigating the progression of cardiac diseases. By leveraging the potential of gene delivery systems, researchers are exploring avenues to address conditions such as heart failure, hypertrophic cardiomyopathy, and other genetic cardiovascular disorders. The evolving field of cardiac gene therapy signifies a paradigm shift, offering hope for more targeted and personalized interventions in the quest for improved heart health. As scientists continue to unravel the complexities of cardiac genetics, the potential for groundbreaking advancements in treating cardiovascular diseases through gene-based approaches remains a captivating area of exploration and development.

Committee Members
Speaker at International Heart Congress 2026 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2026 - Narendra Kumar

Narendra Kumar

HeartbeatsZ Academy, United Kingdom
Speaker at International Heart Congress 2026 - Miroslav Radenkovic

Miroslav Radenkovic

University of Belgrade, Serbia

Submit your abstract Today

Watsapp